| Title : Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study - Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| Author(s) : Sadowsky CH , Farlow MR , Atkinson L , Steadman J , Koumaras B , Chen M , Mirski D |
| Ref : Prim Care Companion J Clin Psychiatry , 7 :43 , 2005 |
| Abstract : |
| PubMedSearch : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| PubMedID: 15841194 |
| Title : Impact of rivastigmine use on the risk of nursing home placement in a US sample - Beusterien_2004_CNS.Drugs_18_1143 |
| Author(s) : Beusterien KM , Thomas SK , Gause D , Kimel M , Arcona S , Mirski D |
| Ref : CNS Drugs , 18 :1143 , 2004 |
| Abstract : |
| PubMedSearch : Beusterien_2004_CNS.Drugs_18_1143 |
| PubMedID: 15581384 |
| Title : Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine - Suh_2004_Drugs.Aging_21_395 |
| Author(s) : Suh DC , Arcona S , Thomas SK , Powers C , Rabinowicz AL , Shin H , Mirski D |
| Ref : Drugs & Aging , 21 :395 , 2004 |
| Abstract : |
| PubMedSearch : Suh_2004_Drugs.Aging_21_395 |
| PubMedID: 15084141 |
| Title : Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial - Farlow_2003_Arch.Neurol_60_843 |
| Author(s) : Farlow M , Potkin S , Koumaras B , Veach J , Mirski D |
| Ref : Archives of Neurology , 60 :843 , 2003 |
| Abstract : |
| PubMedSearch : Farlow_2003_Arch.Neurol_60_843 |
| PubMedID: 12810489 |